A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)

Inclusion Criteria

• •1. Subjects voluntary agreement to provide written informed consent.
• •2. Aged 18 to 70 years, either sex.
• •3. Adequate organ function meet screening criteria.
• •4. Positive test for cluster of differentiation antigen 19 (CD19).
• •SLE:
• •Have been diagnosed of SLE at least 6 months before screening.
• •At screening, antinuclear antibody, and/or anti-dsDNA antibody, and/or anti-Smith antibody should be positive.
• •Fulfill relapsed/refractory SLE conditions.
• •IIM:
• •Have been diagnosed of IIM before screening.
• •Positive test for myositis-associated antibodies or myositis-specific antibodies at screening.
• •Fulfill relapsed/refractory IIM conditions.